SAN RAFAEL — BioMarin Pharmaceutical (Nasdaq: BMRN) completed its $116.5 million purchase of the 13-acre San Rafael Corporate Center campus with headquarters for the developer of treatments for rare diseases, the seller said Tuesday.
